NCT00301639View on ClinicalTrials.gov

A PET Study Examining Pharmacokinetics and Dopamine Transporter Receptor Occupancy Of Two Long-Acting Formulations of Methylphenidate in Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Healthy Volunteers
Interventions
DRUG

OROS methylphenidate hydrochloride

DRUG

methylphenidate hydrochloride

Trial Locations (1)

02138

Massachusetts General Hospital, Cambridge

All Listed Sponsors
collaborator

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT00301639 - A PET Study Examining Pharmacokinetics and Dopamine Transporter Receptor Occupancy Of Two Long-Acting Formulations of Methylphenidate in Adults | Biotech Hunter | Biotech Hunter